Lifespan of a single <i>T. utriculata</i> rosette. by Alexandra M. Campbell (3284094)

Subjects:

A noxious temperature decrease without a prior increase produces a subtly larger decrease in pain intensity. by Benedict J. Alter (9745466)

Correlations of cytokines that significantly change between the pre-infusion and post-infusion blood draws pearson’s correlation between cytokine pairs is indicated by color and si... by Jordan K. Abbott (8934239)

Subjects:

Larger example of stimuli with cue relevant for Task 3. by Marcel F. Hinss (14675457)

Input parameters for the base-case analysis. by R. J. S. D. Heine (17889199)

Subjects:

Points represent regions where the cluster coefficient was significantly larger in HC compared to MCI, at sparsity level of 0.15. by Therese M. Gilligan (7460906)

Comparison of membrane potential variance conditionally around spike events. by Evan Cudone (5768813)

Subjects:

Exploring the Potential of Metal–Organic Frameworks for Cryogenic Helium-Based Gas Gap Heat Switches via High-Throughput Computational Screening by Lingxiao Qin (18181961)

“…Structure–performance analysis reveals that 1/<i>v</i>_sor consistently increases first and then decreases with pore limiting diameter, largest cavity diameter, available pore volume, accessible surface area, helium void fraction, and bulk density. …”

Decrease of injuries. by Petr Fulin (8380320)

Subjects:

Example of predicted effects of choice bundling on preference for larger, later rewards (LLRs) over smaller, sooner rewards (SSRs). by Jeffrey S. Stein (11689918)

Implementation of indication-based pricing (10^th scenario) for daratumumab and pembrolizumab. by R. J. S. D. Heine (17889199)

Subjects:

Mesh independence test based on velocity field of the minimum air supply. by Renquan Tu (19556120)

Subjects:

Three-dimensional bar chart based on the relative probability of infection distribution. by Renquan Tu (19556120)

Subjects:

Scenario analysis for pembrolizumab using a cumulative cost-based price per year per vial. by R. J. S. D. Heine (17889199)

Subjects:

Inputs utilized in base-case and scenario analysis for daratumumab and pembrolizumab, both unadjusted and adjusted for PPP and inflation. by R. J. S. D. Heine (17889199)

Subjects:

Scenario analysis for daratumumab using a cumulative cost-based price per year per vial. by R. J. S. D. Heine (17889199)

Subjects:

Decrease of admissions and lead diagnoses. by Petr Fulin (8380320)

Subjects:

The distribution of <i>Giardia duodenalis</i> assemblages in domestic and wild populations of nonhuman mammalian species with a larger number of isolates. by Kareem Hatam-Nahavandi (7384790)

Subjects:

The potential significance of clinical transformation. by Huanfei Ding (17952107)

Sensitivity analyses of seroprevalence with the largest sample size study omitted. by Yu Zhou (89766)